Clinical Trial Update: Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating transfusing young plasma to older adults to reverse epigenetic markers and other signs of aging; currently in Phase 1/Phase 2 wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Snippet

Sponsor: Chandra Duggirala | Conditions: Aging | Phase 1, Phase 2 | Status: UNKNOWN